Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riociguat in Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction
NCT01065454Phase 2Terminated
- Sponsor
- Bayer
- Start
- Apr 2010
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 2 trial of riociguat in pulmonary hypertension (PH), sponsored by Bayer. Started Apr 2010; status: terminated.
02
Drugs
riociguat
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT01065454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01065454.